Impax Labs Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for IMPAX LABS INC, and what generic and branded alternatives to IMPAX LABS INC drugs are available?
IMPAX LABS INC has forty-eight approved drugs.
There is one tentative approval on IMPAX LABS INC drugs.
Summary for Impax Labs Inc
| US Patents: | 0 |
| Tradenames: | 42 |
| Ingredients: | 42 |
| NDAs: | 48 |
Drugs and US Patents for Impax Labs Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Impax Labs Inc | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 205105-003 | Jul 28, 2016 | AB2 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Impax Labs Inc | ALPRAZOLAM | alprazolam | TABLET, EXTENDED RELEASE;ORAL | 077996-002 | Jan 31, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Impax Labs Inc | MIRTAZAPINE | mirtazapine | TABLET, ORALLY DISINTEGRATING;ORAL | 076901-001 | Jun 28, 2005 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Impax Labs Inc | EPIRUBICIN HYDROCHLORIDE | epirubicin hydrochloride | INJECTABLE;INJECTION | 065331-002 | Aug 9, 2007 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
